CDKN2B-AS1 and breast carcinoma: Hence, taken together, the broad and wide array of stimuli, including association with the clinicopathological variables of breast cancer, serum levels of the lncRNAs ANRIL, and more precisely, HIT could serve as an “early” surrogate of disease progression and/or activity that may signal an increased risk of a poor outcome.